0512-80988088
当前位置:首页 >产品中心 >定量POCT产品 >心脏疾病诊断 心脏疾病诊断

cTnI Quantitative Diagnostic Kit

Time-Resolved Fluorescent Immunochromatographic Assay

p>【Introduction】


With time-resolved fluorescence immuno-chromatographic methods as the core technology and based on double-antibody sandwich assay, cardiac troponin I (cTnI) quantitative detection kit is applicable for quantitatively determination of cTnI levels in human blood in vitro.

【Clinical significance】

1. "gold standard" to diagnosis myocardial infarction;
2. Peaked 4-8h after the onset;
3. Assess infarct size and ACS risk assessment;
4. Marker for AMI thrombolytic therapy;
5. Markers after the treatment of AMI;

【Advantages】

1. Advanced: time-resolved fluorescence immunoassay quantitative chromatography, get result within 30s
2. Quantitative: quantitative detection of myocardial infarction markers cTnI, up to pg level
3. Accurate: consistent with results by imported chemiluminescence reagent (r> 0.975)
4. Highly sensitive: lower detection limit <40pg / mL
5. Simple: simple operation, suitable for bedside detection, section for outpatients and emergency call
6. Widely applicable: can be used for outpatient laboratory, emergency laboratory, medical center, cardiology, ICU, and etc.




返回顶部

更早
2016年02月

手持仪器PocRoc 2S获得注册证

2015年10月

再获5个生化项目注册证,光景生化项目达到10项!

2015年07月

获得CE认证

2014年04月

获得4个即时诊断(POCT)产品注册证书

2014年03月

获得5个纳米微球增强生化产品注册证书

2014年02月

获得时间分辨荧光免疫分析仪产品注册证书

2014年01月

何爱民博士入选“国家千人计划创业人才”